转变呼吸道疾病管理:基于CMO的医院制药护理模式
Borja Zarate-Tamames1,2, Noe Garin1,3, Marta Calvin-Lamas4
1Department of Pharmacy, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
Frontiers in pharmacology
|November 8, 2024
概括
一个新的能力-动机-机会 (CMO) 模型通过个性化治疗和利用技术来增强对呼吸系统患者的药物护理. 这种方法在治疗慢性呼吸道疾病方面改善了患者的结果和幸福感.
科学领域:
- 药物治疗和药物护理 药物治疗和药物护理
- 呼吸系统医学 呼吸系统医学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 呼吸道疾病是全球主要的健康问题,患病率不断增加,对发病率和死亡率产生重大影响.
- 目前用于呼吸系统疾病的药物治疗在药物管理,患者的坚持和管理不良影响方面面临挑战.
- 加强药物护理对于改善呼吸道门诊患者的生活质量和整体福祉至关重要.
研究的目的:
- 专门为呼吸系统门诊患者开发一种能力-动机-机会 (CMO) 模型.
- 进行开发的CMO模型的临时验证,以评估其在增强药品护理方面的有效性.
- 改善与药物相关的直接,负责任的护理,以改善患者的治疗结果和生活质量.
主要方法:
- 这是一项从2022年3月到2023年3月进行的横截面,多中心研究.
- 组建一个专家小组,选择呼吸道病理,制定CMO支柱 (能力,动机,机会),并进行临时模型验证.
- 利用患者分层,激励面试以及信息和通信技术 (ICT) 进行远程医疗.
主要成果:
- 该CMO模型包含8种呼吸道疾病,其中22个变量用于将患者分层分为个性化护理的3个优先级.
- 在201名患者的初步测试中,通过分层工具证明了有效的患者分类.
- 动机支柱侧重于坚持和行为改变,而机会支柱则使用ICT建立了远程咨询协议.
结论:
- 开发的CMO模型为优化呼吸系统患者的药物护理提供了一个全面的框架.
- 该模型的重点是以患者为中心的护理,一致的治疗目标和技术集成,以满足患者的各种需求.
- 建议在各种医疗保健系统进行进一步的验证,以确保CMO模型的广泛适用性.
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.6K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.6K
Methods of Documentation VI: Case Management Model
559
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
559
COPD: Management Using Bronchodilators and Corticosteroids
182
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
182
Cystic Fibrosis: Management
143
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
143
Acute Respiratory Failure-V
123
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
123


